Cargando…
Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer
Ovarian cancer is the fifth leading cause of cancer-related mortality in women worldwide. Despite the development of technologies over decades to improve the diagnosis and treatment of patients with ovarian cancer, the survival rate remains dismal, mainly because most patients are diagnosed at a lat...
Autores principales: | Yang, Fang, Tang, Jun, Zhao, Zihao, Zhao, Chunling, Xiang, Yuancai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641226/ https://www.ncbi.nlm.nih.gov/pubmed/34861867 http://dx.doi.org/10.1186/s12958-021-00860-8 |
Ejemplares similares
-
Detection of Methylated Circulating DNA as Noninvasive Biomarkers for Breast Cancer Diagnosis
por: Cheuk, Isabella Wai Yin, et al.
Publicado: (2017) -
Combined assay of Circulating Tumor DNA and Protein Biomarkers for early noninvasive detection and prognosis of Non-Small Cell Lung Cancer
por: Yin, Jian-xin, et al.
Publicado: (2021) -
Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer
por: Chen, Qian, et al.
Publicado: (2019) -
Circulating Tumor DNA as Biomarkers for Cancer Detection
por: Han, Xiao, et al.
Publicado: (2017) -
Can Circulating Cell-Free DNA or Circulating Tumor DNA Be a Promising Marker in Ovarian Cancer?
por: Yu, Ming, et al.
Publicado: (2021)